### Analysis of rs113488022 in the BRAF Gene

The variant **rs113488022** in the **BRAF** gene is a single nucleotide variant (SNV) located on chromosome 7 at position 140753336. Below is a detailed comparison of rs113488022 with other known variants in the same gene, based on the retrieved data and additional knowledge.

---

### 1. **Variant Identification**
- **rs113488022**:
  - **HGVS Notation**: Multiple transcript-specific notations exist, such as:
    - **NM_004333.6:c.1799T>A** (p.Val600Glu)
    - **NM_004333.6:c.1799T>G** (p.Val600Gly)
    - **NM_004333.6:c.1799T>C** (p.Val600Ala)
  - **Gene**: BRAF
  - **Transcript**: NM_004333.6
  - **TogoVar Link**: [TogoVar rs113488022](https://togovar.org/variant/rs113488022)

---

### 2. **Disease Associations**
- **rs113488022** is associated with multiple diseases, including:
  - **Melanoma** (Pathogenic)
  - **Papillary thyroid carcinoma** (Pathogenic)
  - **Non-small cell lung carcinoma** (Pathogenic)
  - **Colorectal cancer** (Pathogenic)
  - **Cardio-facio-cutaneous syndrome** (Likely pathogenic)
- **Other Variants in BRAF**:
  - Variants such as **p.Val600Lys (V600K)** and **p.Val600Asp (V600D)** are also pathogenic and associated with similar cancers, particularly melanoma and colorectal cancer.
  - Some variants in BRAF are associated with **RASopathies**, a group of developmental disorders.

---

### 3. **Literature Evidence**
- **rs113488022** is one of the most studied variants in the BRAF gene, particularly the **p.Val600Glu (V600E)** substitution. It is a well-known driver mutation in cancers and is frequently mentioned in studies on targeted therapies (e.g., BRAF inhibitors like vemurafenib).
- **Other Variants**:
  - Variants like **p.Val600Lys (V600K)** are also well-documented in cancer research but are less common than **p.Val600Glu (V600E)**.

---

### 4. **Allele Frequency Comparison**
- **rs113488022**:
  - **Global Frequency**: Extremely rare in the general population (allele frequency of 1.37 × 10⁻⁶ in gnomAD exomes).
  - **Japanese Population**: No specific allele frequency data for the Japanese population is available for this variant.
- **Other Variants in BRAF**:
  - Variants like **p.Val600Lys (V600K)** are similarly rare in the general population but may have slightly different population-specific frequencies.

---

### 5. **Functional Impact and Predictive Models**
- **rs113488022**:
  - **SIFT**: 0.0 (deleterious)
  - **PolyPhen-2**: Scores range from 0.294 to 0.958 depending on the specific substitution (e.g., p.Val600Glu has a score of 0.935, indicating probably damaging).
  - **AlphaMissense**: 0.9927 (high pathogenicity likelihood for p.Val600Glu).
- **Other Variants in BRAF**:
  - Variants like **p.Val600Lys (V600K)** and **p.Val600Asp (V600D)** also show high pathogenicity scores in predictive models.

---

### 6. **GWAS Findings**
- **rs113488022**:
  - Strongly associated with cancer phenotypes, particularly melanoma, colorectal cancer, and thyroid carcinoma.
- **Other Variants in BRAF**:
  - Variants like **p.Val600Lys (V600K)** are also linked to similar cancer phenotypes but may have different prevalence rates in specific cancers.

---

### Summary of Differences
- **rs113488022** (particularly the **p.Val600Glu (V600E)** substitution) is the most common and well-studied pathogenic variant in the BRAF gene, especially in cancer research.
- Other variants in BRAF, such as **p.Val600Lys (V600K)** and **p.Val600Asp (V600D)**, are less common but also pathogenic and associated with similar diseases.
- The functional impact of rs113488022 is consistently high across predictive models, and it is a key target for cancer therapies, distinguishing it from other variants.

---

### Sources
- TogoVar: [rs113488022](https://togovar.org/variant/rs113488022)
- ClinVar: [VCV000013961](https://www.ncbi.nlm.nih.gov/clinvar/variation/13961)
- gnomAD: [7-140753336-A-T](https://gnomad.broadinstitute.org/variant/7-140753336-A-T?dataset=gnomad_r4)

---

### 日本語での説明

#### rs113488022のBRAF遺伝子内での特徴と他の変異との違い

---

### 1. **変異の識別**
- **rs113488022**:
  - **HGVS表記**: 複数の転写産物に基づく表記が存在します。
    - **NM_004333.6:c.1799T>A** (p.Val600Glu)
    - **NM_004333.6:c.1799T>G** (p.Val600Gly)
    - **NM_004333.6:c.1799T>C** (p.Val600Ala)
  - **遺伝子**: BRAF
  - **転写産物**: NM_004333.6
  - **TogoVarリンク**: [TogoVar rs113488022](https://togovar.org/variant/rs113488022)

---

### 2. **疾患との関連**
- **rs113488022**:
  - **メラノーマ** (病原性)
  - **乳頭状甲状腺癌** (病原性)
  - **非小細胞肺癌** (病原性)
  - **大腸癌** (病原性)
  - **心臓顔面皮膚症候群** (おそらく病原性)
- **BRAFの他の変異**:
  - **p.Val600Lys (V600K)** や **p.Val600Asp (V600D)** も同様に病原性で、特にメラノーマや大腸癌と関連しています。
  - 一部の変異は**RASopathy**（発達障害群）とも関連しています。

---

### 3. **文献的証拠**
- **rs113488022**:
  - 特に**p.Val600Glu (V600E)** 置換は、がん研究や標的治療（例: BRAF阻害剤）で最も研究されている変異の1つです。
- **他の変異**:
  - **p.Val600Lys (V600K)** なども研究されていますが、**p.Val600Glu (V600E)** ほど一般的ではありません。

---

### 4. **アレル頻度の比較**
- **rs113488022**:
  - **全世界頻度**: 一般集団では非常に稀（gnomADエクソームで1.37 × 10⁻⁶）。
  - **日本人集団**: この変異に関する具体的な頻度データはありません。
- **BRAFの他の変異**:
  - **p.Val600Lys (V600K)** なども一般集団では稀ですが、集団ごとに頻度が異なる場合があります。

---

### 5. **機能的影響と予測モデル**
- **rs113488022**:
  - **SIFT**: 0.0（有害）
  - **PolyPhen-2**: 0.294～0.958（p.Val600Gluは0.935で「おそらく有害」）。
  - **AlphaMissense**: 0.9927（p.Val600Gluの病原性の可能性が非常に高い）。
- **BRAFの他の変異**:
  - **p.Val600Lys (V600K)** や **p.Val600Asp (V600D)** も同様に高い病原性スコアを示します。

---

### 6. **GWASの発見**
- **rs113488022**:
  - 特にメラノーマ、大腸癌、甲状腺癌などのがん表現型と強く関連しています。
- **BRAFの他の変異**:
  - **p.Val600Lys (V600K)** なども同様のがん表現型と関連していますが、特定のがんでの発生率が異なる場合があります。

---

### 違いの要約
- **rs113488022**（特に**p.Val600Glu (V600E)** 置換）は、BRAF遺伝子で最も一般的かつ研究されている病原性変異であり、がん研究において重要なターゲットです。
- 他の変異（例: **p.Val600Lys (V600K)**）も病原性ですが、頻度や研究の注目度は**rs113488022**ほどではありません。
- **rs113488022**は、予測モデルで一貫して高い病原性スコアを示し、がん治療の標的として際立っています。

---

### 出典
- TogoVar: [rs113488022](https://togovar.org/variant/rs113488022)
- ClinVar: [VCV000013961](https://www.ncbi.nlm.nih.gov/clinvar/variation/13961)
- gnomAD: [7-140753336-A-T](https://gnomad.broadinstitute.org/variant/7-140753336-A-T?dataset=gnomad_r4)